151 related articles for article (PubMed ID: 35071044)
41. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii.
Awasthi S; Awasthi V; Magee DM; Coalson JJ
J Immunol; 2005 Sep; 175(6):3900-6. PubMed ID: 16148136
[TBL] [Abstract][Full Text] [Related]
42. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
44. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
45. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
46. A review of innate and adaptive immunity to coccidioidomycosis.
Hung CY; Hsu AP; Holland SM; Fierer J
Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of a potential vaccine for Coccidioides immitis.
Barnato AE; Sanders GD; Owens DK
Emerg Infect Dis; 2001; 7(5):797-806. PubMed ID: 11747691
[TBL] [Abstract][Full Text] [Related]
48. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
49. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
50. Vaccines against Coccidioides.
Yoon HJ; Clemons KV
Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
[TBL] [Abstract][Full Text] [Related]
51. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).
Johnson SM; Lerche NW; Pappagianis D; Yee JL; Galgiani JN; Hector RF
Ann N Y Acad Sci; 2007 Sep; 1111():290-300. PubMed ID: 17347333
[TBL] [Abstract][Full Text] [Related]
52. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
[TBL] [Abstract][Full Text] [Related]
53. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.
Viriyakosol S; Fierer J; Brown GD; Kirkland TN
Infect Immun; 2005 Mar; 73(3):1553-60. PubMed ID: 15731053
[TBL] [Abstract][Full Text] [Related]
54. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
55. Susceptibility to Coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a).
del Pilar Jiménez-A M; Viriyakosol S; Walls L; Datta SK; Kirkland T; Heinsbroek SE; Brown G; Fierer J
Genes Immun; 2008 Jun; 9(4):338-48. PubMed ID: 18418396
[TBL] [Abstract][Full Text] [Related]
56. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
Pappagianis D; Hector R; Levine HB; Collins MS
Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
[TBL] [Abstract][Full Text] [Related]
57. Development of vaccines for coccidioidomycosis.
Levine HB; Pappagianis D; Cobb JM
Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
[No Abstract] [Full Text] [Related]
58. Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.
Shubitz LF; Dial SM; Perrill R; Casement R; Galgiani JN
Infect Immun; 2008 Dec; 76(12):5553-64. PubMed ID: 18852250
[TBL] [Abstract][Full Text] [Related]
59. Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis.
Powell DA; Hsu AP; Shubitz LF; Butkiewicz CD; Moale H; Trinh HT; Doetschman T; Georgieva TG; Reinartz DM; Wilson JE; Orbach MJ; Holland SM; Galgiani JN; Frelinger JA
Immunohorizons; 2022 Feb; 6(2):130-143. PubMed ID: 35149520
[TBL] [Abstract][Full Text] [Related]
60. Susceptibility of TLR4-defective C3H/HeJ mice to Coccidioides posadasii infection.
Awasthi S
Med Mycol; 2010 May; 48(3):470-5. PubMed ID: 20370361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
